{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:32:39Z","timestamp":1790865159837,"version":"4.1.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:title>Graphical Abstract<\/jats:title><jats:p\/>","DOI":"10.3389\/ti.2022.10109","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:11:03Z","timestamp":1652872263000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients"],"prefix":"10.3389","volume":"35","author":[{"given":"Friederike","family":"Bachmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Lingscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Songa","family":"Stegemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilgin","family":"Osmanodja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Duettmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas Johannes","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Duerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Waiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Halleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of Immune Response during SARS-CoV-2 Infection: Lessons from the Past","volume":"11","author":"Shah","year":"2020","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY): a Randomised, Controlled, Open-Label, Platform Trial","volume":"397","author":"Horby","year":"2021","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"jiab142","DOI":"10.1093\/infdis\/jiab142","article-title":"Rapidly Increasing SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced from Plasma Collected during the 2020 Pandemic","author":"Farcet","year":"2021","journal-title":"J Infect Dis"},{"key":"B5","first-page":"201","article-title":"An EUA for Casirivimab and Imdevimab for COVID-19","volume":"62","year":"2020","journal-title":"Med Lett Drugs Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"p2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent Plasma in Patients Admitted to Hospital with COVID-19 (RECOVERY): a Randomized Controlled, Open-Label, Platform Trial","year":"2021","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/nejmoa2029849","article-title":"SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19","volume":"384","author":"Chen","year":"2021","journal-title":"N Engl J Med"},{"key":"B8","unstructured":"Emergency Use Authorization (EUA) for Bamlanivimab 700mg IV Center for Drug Evaluation and Research (CDER) Review2021"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1854149","DOI":"10.1080\/19420862.2020.1854149","article-title":"Anti-SARS-CoV-2 Neutralizing Monoclonal Antibodies: Clinical Pipeline","volume":"12","author":"Tuccori","year":"2020","journal-title":"MAbs"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies in Humanized Mice and Convalescent Humans Yield a SARS-CoV-2 Antibody Cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"B11","first-page":"NEJMoa2035002","article-title":"REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19","author":"Weinreich","year":"2020","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK Patients in Hospital with COVID-19 Using the ISARIC WHO Clinical Characterisation Protocol: Prospective Observational Cohort Study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"20202083","DOI":"10.1093\/ndt\/gfaa271","article-title":"Mortality Analysis of COVID-19 Infection in Chronic Kidney Disease, Haemodialysis and Renal Transplant Patients Compared With\u00a0patients without Kidney Disease: a Nationwide Analysis from Turkey","volume":"35","author":"Ozturk","year":"2020","journal-title":"Nephrol Dial Transpl"},{"key":"B14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/tri.13881","article-title":"Undoubtedly, Kidney Transplant Recipients Have a Higher Mortality Due to COVID\u201019 Disease Compared to the General Population","volume":"34","author":"Osmanodja","year":"2021","journal-title":"Transpl Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/nejmc2011117","article-title":"Covid-19 and Kidney Transplantation","volume":"382","author":"Akalin","year":"2020","journal-title":"N Engl J Med"},{"key":"B16","first-page":"32901","article-title":"Coronavirus Disease 2019 in Kidney Transplant Patients from a Large UK Transplant Center: Exploring Risk Factors for Disease Severity","author":"Sran","year":"2020","journal-title":"Transpl Proc"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab305","article-title":"Real- World Experience of Bamlanivimab for COVID_19: A Case-Control Study","author":"Kumar","year":"2021","journal-title":"Clin Inf Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1097\/TP.0000000000003883","article-title":"Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-Organ Transplant Patients","volume":"105","author":"Del Bello","year":"2021","journal-title":"Transplant June"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e61971","DOI":"10.3791\/61971","article-title":"TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients","volume":"2021","author":"Schmidt","year":"2021","journal-title":"JoVE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3201\/eid2702.204443","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak Related to a Nightclub, Germany, 2020","volume":"27","author":"Muller","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e61899","DOI":"10.3791\/61899","article-title":"Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform","volume":"170","author":"Duettmann","year":"2021","journal-title":"JoVE"},{"key":"B22","doi-asserted-by":"publisher","first-page":"eabf1906","DOI":"10.1126\/scitranslmed.abf1906","article-title":"The Neutralizing Antibody, LY-CoV555, Protects against SARS-CoV-2 Infection in Nonhuman Primates","volume":"13","author":"Jones","year":"2021","journal-title":"Sci Transl Med"},{"key":"B23","first-page":"434607","article-title":"The Dual Function Monoclonal Antibodies VIR-7831 and VIR-7832 Demonstrate Potent In Vitro and In Vivo Activity against SARS-CoV-2 bioRxiv 2021.03.09","author":"Cathcart","year":""},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly Neutralizing Antibodies Overcome SARS-CoV-2 Omicron Antigenic Shift","volume-title":"bioRxiv preprint","author":"Cameroni","year":""}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2022.10109\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:11:10Z","timestamp":1652872270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2022.10109\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":24,"alternative-id":["10.3389\/ti.2022.10109"],"URL":"https:\/\/doi.org\/10.3389\/ti.2022.10109","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"article-number":"10109"}}